Chicago, IL, United States of America

Steven R Martinez

This inventor holds 1 USPTO granted patent. Top assignee: Abbvie Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven R Martinez. Retrieved from https://idiyas.com/inventor/steven-r-martinez-cebm1ugc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Steven R. Martinez

Introduction

Steven R. Martinez is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of antiviral research, particularly in the development of compounds effective against Hepatitis C virus (HCV). His work has the potential to impact the treatment of HCV infections significantly.

Latest Patents

Steven holds a patent for anti-viral compounds that are effective in inhibiting the activity of HCV polymerase. This invention not only features the compounds themselves but also includes processes for making these compounds, compositions that comprise them, and methods for using them to treat HCV infections. This patent represents a crucial advancement in the fight against viral infections.

Career Highlights

Steven is currently employed at AbbVie Inc., a global biopharmaceutical company known for its innovative research and development in various therapeutic areas. His role at AbbVie allows him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Steven's notable coworkers include Jaclyn Chau and Hui-Ju J. Chen. Their collaborative efforts in research and development have further enhanced the potential of the compounds developed by Steven.

Conclusion

Steven R. Martinez is a notable inventor whose work in antiviral compounds showcases his dedication to advancing medical science. His contributions have the potential to improve treatment options for those affected by Hepatitis C virus.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…